How does SkinVive differ from regular filler?

The mistake here is to hear "injectable" and assume SkinVive is simply another filler. The wording used to describe it is more specific than that, and the specifics are what to compare.

How the approval describes it

The page at www.dermatologytimes.com says the FDA approved Skinvive by Juvederm, the first hyaluronic acid intradermal microdroplet injection, for improving skin smoothness in adult patients ages 21 and older. Three phrases stand out: microdroplet, intradermal and skin smoothness. Each is a stated detail of what this product was approved to do.

Reading the difference without overreaching

That description names a goal of smoother skin. Whether it behaves differently from a filler you may have heard of is something to ask a provider to explain, using the product's own terms. Do not accept a comparison from a headline alone.

The AbbVie announcement of the FDA approval is the company's account. Glam frames the product as an injectable that doubles as skincare, which is a friendly summary and not a technical comparison.

The step to leave to a clinician

Picking between a skin-smoothing injection and a conventional filler depends on your face and your goal. That choice belongs with a licensed clinician who can examine you, not with a chart you read online.

The warning to carry out

Do not let "it is not really a filler" talk you out of the caution you would bring to any injection. Ask who is injecting, where they trained, and what happens if you are unhappy with the result.